Organization

Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University

2 abstracts

Abstract
Racial differences in genomic profiles and targeted treatment use in ER+ HER2- metastatic breast cancer.
Org: Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS,
Abstract
Prognostic value of TP53 mutation status in metastatic triple-negative and hormone receptor-positive breast cancer using cell-free DNA genomic profiling.
Org: Mass General Brigham-Salem Hospital, Massachusetts General Hospital Cancer Center, Surgical Oncology, Boston, MA, Massachusetts General Hospital, Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY,